Release Date: 04/09/12 10:22 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 109.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%